Free Trial

Lipella Pharmaceuticals (LIPO) SEC Filings & 10K Form

Lipella Pharmaceuticals logo
$2.64 -0.31 (-10.51%)
(As of 11/13/2024 ET)

Recent Lipella Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/07/2024
4:01 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:24 PM
Lipella Pharmaceuticals (Filer)
Form PRE 14A
11/01/2024
4:00 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
3:05 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:00 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2024
4:00 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
09/11/2024
4:10 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
3:05 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
08/13/2024
3:13 PM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
7:44 AM
Lipella Pharmaceuticals (Filer)
Form ARS
08/12/2024
7:25 AM
Lipella Pharmaceuticals (Filer)
Form DEF 14A
08/06/2024
3:50 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
4:20 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
10:50 AM
Lipella Pharmaceuticals (Filer)
Form 424B5
05/15/2024
3:39 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:15 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:15 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:15 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
5:25 PM
Lipella Pharmaceuticals (Issuer)
Yoshimura Naoki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:26 PM
Lipella Pharmaceuticals (Issuer)
Pruchnic Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:15 PM
Kim Byong (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:18 PM
Cohen Daniel R (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:19 PM
Johnston Douglas (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:21 PM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:22 PM
Birder Lori (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:24 PM
Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
12:31 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
11:19 AM
Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:20 AM
Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:13 AM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
03/15/2024
11:15 AM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
03/15/2024
5:04 AM
Lipella Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
4:03 PM
Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
03/06/2024
4:05 PM
Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13D/A
02/08/2024
11:15 PM
Lipella Pharmaceuticals (Filer)
Form EFFECT
02/07/2024
4:29 PM
Gruber Michele (Filed by)
Lipella Pharmaceuticals (Subject)
Form SC 13G/A
11/28/2023
4:28 PM
Lipella Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2023
5:22 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
11/14/2023
5:22 AM
Lipella Pharmaceuticals (Filer)
Form 424B3
11/14/2023
5:14 AM
Lipella Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIPO) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners